AC Immune (ACIU) Cash from Operations (2015 - 2025)
AC Immune (ACIU) posted quarterly Cash from Operations of 20932070.62 for Q4 2025, down 409.02% year-over-year from 6773790.65 in Q4 2024, and up 10.36% quarter-over-quarter from 23352045.73 in Q3 2025.
AC Immune (ACIU) Cash from Operations (2015 - 2025) Analysis & Trends
AC Immune (ACIU) has reported Cash from Operations for 11 consecutive years, with 20932070.62 the latest figure, recorded in Q4 2025.
- In Q4 2025, Cash from Operations fell 409.02% year-over-year to 20932070.62; the TTM figure through Dec 2025 stood at 85385299.71 (down 217.97% YoY), while the FY2025 annual figure was 85598939.26, down 213.89% from the prior year.
- Cash from Operations improved to 20932070.62 in Q4 2025 per ACIU's latest filing, from 23352045.73 in the prior quarter.
- Across five years, Cash from Operations topped out at 80752780.98 in Q2 2024 and bottomed at 25059434.29 in Q1 2022.
- Historically, Cash from Operations has averaged 11495192.53 across 5 years, with a median of 18116729.95 in 2022.
- Annual changes were most pronounced in 2024 — Cash from Operations jumped 611.76% — and 2025, when it tumbled 1935.27%.
- AC Immune's Cash from Operations stood at 19334503.4 in 2021, then climbed by 6.55% to 18068847.43 in 2022, then dropped by 2.14% to 18454792.73 in 2023, then jumped by 136.7% to 6773790.65 in 2024, then slumped by 409.02% to 20932070.62 in 2025.
- Business Quant data shows ACIU's Cash from Operations at 20932070.62 in Q4 2025, 23352045.73 in Q3 2025, and 19570237.49 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.13 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 813.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -387.32 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 462.82 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 728.46 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 326.72 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -88.83 Mn |
| 10 | AC Immune | 253.89 Mn | 253.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.93 Mn |
| Dec 31, 2025 | -20.93 Mn |
| Sep 30, 2025 | -23.35 Mn |
| Sep 30, 2025 | -23.35 Mn |
| Jun 30, 2025 | -19.57 Mn |
| Jun 30, 2025 | -19.57 Mn |
| Mar 31, 2025 | -21.53 Mn |
| Mar 31, 2025 | -21.53 Mn |
| Dec 31, 2024 | 6.77 Mn |
| Dec 31, 2024 | 6.77 Mn |
| Sep 30, 2024 | -16.32 Mn |
| Sep 30, 2024 | -16.32 Mn |
| Jun 30, 2024 | 80.75 Mn |
| Jun 30, 2024 | 80.75 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | -18.45 Mn |
| Dec 31, 2023 | -18.45 Mn |
| Sep 30, 2023 | -15.25 Mn |
| Sep 30, 2023 | -15.25 Mn |